← Leaderboards
David L Farrens
Oregon Health And Science University
$7,649,603
Attributed
$7,649,603
Total exposure
8
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $521K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,649,603 · 8
By mechanism
R01$6,292,505 · 4
R21$1,140,330 · 3
S10$216,768 · 1
Top collaborators
No co-investigators on record.
Most similar at Oregon Health And Science University
Same institution · by research overlap
- Kim Arthur Neve$10,213,177
- John T Williams$20,574,237
- Ronald Lane Brown$4,814,875
- Seksiri Arttamangkul$625,374
- Roger D Cone$16,020,690
Others in their field
Top investigators on “Rhodopsin”
- Krzysztof Palczewski · University Of California-Irvine$28,849,719
- Craig Montell · University Of California Santa Barbara$23,074,142
- John L Spudich · University Of Texas Hlth Sci Ctr Houston$18,566,744
- Claude Desplan · New York University$17,021,591
- Jeannie Chen · University Of Southern California$14,439,003
- Vsevolod V. Gurevich · Sun Health Research Institute$14,360,682
Research focus
RhodopsinReceptorProteinsG-Protein-Coupled ReceptorsMolecularPharmacologic SubstanceStructureEventPharmaceutical PreparationsOpsinKineticsAffectLightComplexFamilyArrestinsPlayAttenuatedNonexudative Age-Related Macular DegenerationLigandsAttenuationChromophoreNight BlindnessAdduct
Grant awards (27)
Structural Dynamics in Rhodopsin Activation and Attenuation$520,978
R01 · FY2025 · EY · contact PI
Structural Dynamics in Rhodopsin Activation and Attenuation$385,000
R01 · FY2023 · EY · contact PI
Structural Dynamics in Rhodopsin Activation and Attenuation$373,449
R01 · FY2022 · EY · contact PI
Structural Dynamics in Rhodopsin Activation and Attenuation$373,449
R01 · FY2021 · EY · contact PI
Structural Dynamics in Rhodopsin Activation and Attenuation$385,000
R01 · FY2020 · EY · contact PI
Structural Dynamics in Rhodopsin Activation and Attenuation$398,500
R01 · FY2019 · EY · contact PI
Crystallization and Structural Analysis of the Human Cannabinoid Receptor CB1$192,500
R21 · FY2018 · DA · contact PI
Identifying Dynamic Equilibrium Binding of Retinal and Non-retinal Ligands to Rhodopsin$192,500
R21 · FY2018 · EY · contact PI
Identifying Dynamic Equilibrium Binding of Retinal and Non-retinal Ligands to Rhodopsin$231,000
R21 · FY2017 · EY · contact PI
Crystallization and Structural Analysis of the Human Cannabinoid Receptor CB1$231,000
R21 · FY2017 · DA · contact PI
Structural Dynamics of Retinal Binding and Release$374,389
R01 · FY2014 · EY · contact PI
Structural Dynamics of Retinal Binding and Release$362,929
R01 · FY2013 · EY · contact PI
Structural Dynamics of Retinal Binding and Release$382,030
R01 · FY2012 · EY · contact PI
Structural Dynamics of Retinal Binding and Release$382,030
R01 · FY2011 · EY · contact PI
Flourescence and Luminescense Lifetime Instrument$216,768
S10 · FY2010 · RR · contact PI
Structural Dynamics of Retinal Binding and Release$264,425
R01 · FY2009 · EY · contact PI
Structural Dynamics of Retinal Binding and Release$256,452
R01 · FY2008 · EY · contact PI
Structural Dynamics of Retinal Binding and Release$261,625
R01 · FY2007 · EY · contact PI
Purification & Structural Analysis/Cannabinoid Receptor$214,763
R01 · FY2007 · DA · contact PI
Structural Dynamics of Retinal Binding and Release$268,501
R01 · FY2006 · EY · contact PI
Purification & Structural Analysis/Cannabinoid Receptor$221,177
R01 · FY2006 · DA · contact PI
Purification &Structural Analysis/Cannabinoid Receptor$226,500
R01 · FY2005 · DA
Purification &Structural Analysis/Cannabinoid Receptor$243,850
R01 · FY2004 · DA
Purification &Structural Analysis/Cannabinoid Receptor$151,000
R21 · FY2002 · DA
THE ROLE OF CONFORMATIONAL CHANGES AND RHODOPSIN$201,666
R01 · FY2001 · EY
Purification &Structural Analysis/Cannabinoid Receptor$142,330
R21 · FY2001 · DA
THE ROLE OF CONFORMATIONAL CHANGES AND RHODOPSIN$195,792
R01 · FY2000 · EY